VolitionRx (VNRX) Competitors

LifeVantage (NASDAQ:LFVN) and VolitionRx (NYSE:VNRX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, community ranking, analyst recommendations, profitability and valuation.

Do insiders & institutionals have more ownership in LFVN or VNRX?

35.3% of LifeVantage shares are held by institutional investors. Comparatively, 8.1% of VolitionRx shares are held by institutional investors. 20.7% of LifeVantage shares are held by company insiders. Comparatively, 10.4% of VolitionRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Which has better earnings & valuation, LFVN or VNRX?

LifeVantage has higher revenue and earnings than VolitionRx. VolitionRx is trading at a lower price-to-earnings ratio than LifeVantage, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeVantage	$222.35M	0.72	$2.94M	$0.69	18.45
VolitionRx	$1.31M	39.40	-$35.32M	-$0.27	-1.89

Does the MarketBeat Community favor LFVN or VNRX?

LifeVantage received 209 more outperform votes than VolitionRx when rated by MarketBeat users. Likewise, 77.97% of users gave LifeVantage an outperform vote while only 19.72% of users gave VolitionRx an outperform vote.

Company	Underperform	Outperform
LifeVantage	Outperform Votes 223 77.97%	Underperform Votes 63 22.03%
VolitionRx	Outperform Votes 14 19.72%	Underperform Votes 57 80.28%

Does the media refer more to LFVN or VNRX?

In the previous week, VolitionRx had 8 more articles in the media than LifeVantage. MarketBeat recorded 9 mentions for VolitionRx and 1 mentions for LifeVantage. LifeVantage's average media sentiment score of 1.76 beat VolitionRx's score of 0.69 indicating that LifeVantage is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeVantage	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
VolitionRx	2 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Is LFVN or VNRX more profitable?

LifeVantage has a net margin of 3.46% compared to VolitionRx's net margin of -2,321.14%. LifeVantage's return on equity of 34.29% beat VolitionRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeVantage	3.46%	34.29%	15.04%
VolitionRx	-2,321.14%	N/A	-163.39%

Do analysts prefer LFVN or VNRX?

LifeVantage presently has a consensus price target of $30.50, suggesting a potential upside of 139.59%. VolitionRx has a consensus price target of $3.75, suggesting a potential upside of 633.14%. Given VolitionRx's higher probable upside, analysts clearly believe VolitionRx is more favorable than LifeVantage.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeVantage	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
VolitionRx	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Which has more volatility & risk, LFVN or VNRX?

LifeVantage has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, VolitionRx has a beta of 1, suggesting that its share price has a similar volatility profile to the S&P 500.

Summary

LifeVantage beats VolitionRx on 13 of the 17 factors compared between the two stocks.